TY - JOUR
T1 - Cloning, expression and characterization of the murine orthologue of SBF2, the gene mutated in Charcot-Marie-Tooth disease type 4B2
AU - Kirfel, Jutta
AU - Senderek, Jan
AU - Moser, Markus
AU - Röper, Anke
AU - Stendel, Claudia
AU - Bergmann, Carsten
AU - Zerres, Klaus
AU - Buettner, Reinhard
N1 - Funding Information:
The authors thank Gerrit Klemm for excellent digital artwork. This work was supported by a grant from the Deutsche Forschungsgemeinschaft to J.K. and R.B.
Copyright:
Copyright 2011 Elsevier B.V., All rights reserved.
PY - 2006/10/2
Y1 - 2006/10/2
N2 - Autosomal recessive hereditary motor and sensory neuropathy (HMSN) or Charcot-Marie-Tooth disease (CMT) is a clinically and genetically heterogeneous disorder of the peripheral nervous system. The clinical picture includes progressive distal weakness and atrophy, foot deformities, and distal sensory loss. For autosomal recessive CMT type 4B2 one locus was mapped to chromosome 11p15. Recently, mutations in SET binding factor 2 (SBF2), were identified as cause of CMT4B2. SBF2 is a member of the pseudo-phosphatase branch of myotubularins and all disease-associated mutations known to date lead to shortened or truncated proteins, also implicating loss-of-function. Here, we describe the molecular cloning and the expression pattern of Sbf2. The mRNA spans around 8 kb, and the protein shares high amino acid identity compared to the human protein suggesting a conserved function. Sbf2 is encoded by 40 exons on murine chromosome 7. In situ hybridization, Northern blots and RT-analysis revealed a very broad pattern of Sbf2 expression. Overexpressed epitope tagged Sbf2 showed cytoplasmic distribution. Taken together, this study provides information about the mRNA expression and subcellular localization of Sbf2 and as such helps in further understanding its function in development and disease.
AB - Autosomal recessive hereditary motor and sensory neuropathy (HMSN) or Charcot-Marie-Tooth disease (CMT) is a clinically and genetically heterogeneous disorder of the peripheral nervous system. The clinical picture includes progressive distal weakness and atrophy, foot deformities, and distal sensory loss. For autosomal recessive CMT type 4B2 one locus was mapped to chromosome 11p15. Recently, mutations in SET binding factor 2 (SBF2), were identified as cause of CMT4B2. SBF2 is a member of the pseudo-phosphatase branch of myotubularins and all disease-associated mutations known to date lead to shortened or truncated proteins, also implicating loss-of-function. Here, we describe the molecular cloning and the expression pattern of Sbf2. The mRNA spans around 8 kb, and the protein shares high amino acid identity compared to the human protein suggesting a conserved function. Sbf2 is encoded by 40 exons on murine chromosome 7. In situ hybridization, Northern blots and RT-analysis revealed a very broad pattern of Sbf2 expression. Overexpressed epitope tagged Sbf2 showed cytoplasmic distribution. Taken together, this study provides information about the mRNA expression and subcellular localization of Sbf2 and as such helps in further understanding its function in development and disease.
UR - http://www.scopus.com/inward/record.url?scp=33748150371&partnerID=8YFLogxK
U2 - 10.1016/j.modgep.2006.04.005
DO - 10.1016/j.modgep.2006.04.005
M3 - Journal articles
C2 - 16750429
AN - SCOPUS:33748150371
SN - 1567-133X
VL - 6
SP - 978
EP - 984
JO - Gene Expression Patterns
JF - Gene Expression Patterns
IS - 8
ER -